H2BB Training Days Have Begun
Last week OBIO hosted our newest H2BB trainees for the introductory sessions of our Innovation & Commercialization and Project Management training modules.
Reviewing the 2020 Niagara Investment Summit – Day 2: Jeff Karp Keynote Address
Reviewing the 2020 Niagara Investment Summit – What were you saying?
Reviewing the 2020 Niagara Investment Summit – Day 2: Dr. Dave Williams Keynote Address
Reviewing the 2020 Niagara Investment Summit – Day 1: Early Technology Showcase
2020 Niagara Investment Summit a Success
The 2020 Niagara Investment Summit brought together a record number of health science industry leaders, entrepreneurs and global investors to meet, learn and be inspired. Summaries and photo galleries are now available.
Weston Brain Institute Now Accepting Grant Applications
The Weston Brain Institute is accepting applications for its research grant programs supporting translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging.
Future of Health Care in Canada: OBIO Investment Summit Connects Global Investors, Leading-Edge Health Companies
Last week, 43 of the most promising companies in the Canadian health science industry came together at the OBIO Niagara Investment Summit, where they showcased their innovations to over 40 investors from across North America and Japan to pave the path to the investments needed to fully commercialize products.
Stem Cell Network Announces Competition for Stem-Cell Based Technologies or Therapies
Stem Cell Network announces funding competition for stem-cell based technologies or therapies
University of Toronto Professor Elected to U.S. National Academy of Engineering
University of Toronto professor elected as an international member of the U.S. National Academy of Engineering (NAE).
KITE Power Play Pitch Competition
Toronto Rehab Foundation, in partnership with KITE Research Institute, is hosting the second Power Play Pitch Competition.
New investments for Xpan Inc. and Nanology Labs
XPan Inc. and Nanology Labs receive new follow-on investments from FACIT.
VoxNeuro Announces Research Project with St. Joseph's Healthcare Hamilton
VoxNeuro’s Cognitive Health Assessments™ will be used alongside blood tests and various behavioural and clinical assessments to identify biomarkers of bipolar disorder.
Aspect Biosystems Announces US$20 Million Series A Financing
Fusion Pharmaceuticals receives investment commitment of up to US$20M
VBI Vaccines Announces Sci-B-Vac®Phase 3 Study Meets Primary and Secondary Endpoints
VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, has reported that the Phase 3 study of its trivalent hepatitis B vaccine has met both primary and secondary endpoints for safety and efficacy.
Apply for the Canadian Technology Accelerator - Health Programs
The Trade Commissioner Service is currently recruiting for the Canadian Technology Accelerator cohort for life sciences start-ups and companies seeking to expand in the US and Asia.
Deep Genomics raises $40 million in Series B round
Toronto-based Deep Genomics, which has developed a platform that uses deep learning to create therapies, has closed a $40 million Series B round.
ProteinQure named one of CB Insights' Game Changers for 2020
ProteinQure, which has designed a platform to automate the computational design of protein-based drugs, has been named one of CB Insights’ Game Changers for 2020.
Synaptive Medical Announces Close of $25M Preferred Share Financing
Synaptive Medical, a Toronto-based medical and technology company solving surgical, imaging and data challenges, has completed a first round of investment totaling $25,000,000 USD.